Osteoporosis continues to be one of the major causes of fractures and falls amongst Americans beyond the age of 50 years. The disease is currently affecting close to 54 million United States adults who have very weak bones that cannot support their body frames.
The current treatment therapies for this disease include; the application of the short term hormone replacement method, use of bisphosphonates, and finally teriparatide.
The public should note that the short term hormone replacement method is useful in supplying the body’s bones with mineral density making them strong. However, there are side effects related to the application of this therapy including cardiovascular diseases, cancers and thrombosis. Therefore, people should be wary of this treatment method.
Secondly, bisphosphonates play the role of improving the mineral density of bones thereby preventing of fractures in old people. This medication works by breaking down bone tissues eventually leading to the regeneration of these parts of the body. A side effect of the therapy, however, is that the medication continues to work even when the usage has been stopped. Such an instance leads to an increase in bone matter in the spinal cord.
The last treatment method of managing osteoporosis is by utilizing teriparatide which acts by decreasing any possibilities of fractures in postmenopausal women suffering from osteoporosis. It has been proven that this method of treatment improves the mineral density of bones leading to reduced cases of fractures.
Sincerely
\Name
References
Cosman, F., De Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014). Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis international, 25(10), 2359-2381.
Cummings, S. R., Cosman, F., Eastell, R., Reid, I. R., Mehta, M., & Lewiecki, E. M. (2013). Goal‐directed treatment of osteoporosis. Journal of Bone and Mineral Research, 28(3), 433-438.
